Avasimibe and Sirt 1 Activators Reverse NAFLD and Obesity

Ian James Martins
Additional contact information
Ian James Martins: Centre of Excellence in Alzheimer’s disease Research and Care, School of Medical Sciences, Edith Cowan University, Australia

Novel Approaches in Drug Designing & Development, 2017, vol. 1, issue 3, 38-39

Abstract: In epidemiological studies human obesity is clearly associated with the increased risk for atherosclerosis contributing to the early onset of coronary artery disease and diabetes. Visceral obesity in particular increases the risk of atherosclerosis owing to both insulin resistance and dyslipoproteinemia. Risk factors for atherosclerosis that could be exacerbated by obesity include hypertension and hyper lipidemia particularly hyper triglyceridemia which are risk factors for Alzheimer’s disease. The susceptibility of humans to obesity is far higher compared with other species and in man favours the deposition of fat [1].

Keywords: juniper publishers; drug designing pdf; drug designing articles; drug designing abstract; drug designing journal; modern approaches in drug designing journal; drug designing & intellectual properties international journal; peer reviewed open access journals; high impact journals; juniper publishers review (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://juniperpublishers.com/napdd/pdf/NAPDD.MS.ID.555561.pdf (application/pdf)
https://juniperpublishers.com/napdd/NAPDD.MS.ID.555561.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jnapdd:v:1:y:2017:i:3:p:38-39

DOI: 10.19080/NAPDD.2017.01.555561

Access Statistics for this article

Novel Approaches in Drug Designing & Development is currently edited by Sophia Mathis

More articles in Novel Approaches in Drug Designing & Development from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().